Crumly & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $408K | Buy |
|
|||||
|
2024
Q4 | $338K | Buy |
|
|||||
|
2024
Q3 | $312K | Sell |
|
|||||
|
2024
Q2 | $308K | Buy |
|
|||||
|
2024
Q1 | $222K | Buy |
|
|||||
|
2023
Q4 | $210K | Sell |
|
|||||
|
2023
Q3 | $570K | Buy |
|
|||||
|
2023
Q2 | $627K | Sell |
|
|||||
|
2023
Q1 | $825K | Buy |
|
|||||
|
2022
Q4 | $1.02M | Sell |
|
|||||
|
2022
Q3 | $878K | Sell |
|
|||||
|
2022
Q2 | $1.06M | Buy |
|
|||||
|
2022
Q1 | $1.01M | Buy |
|
|||||
|
2021
Q4 | $1.01M | Buy |
|
|||||
|
2021
Q3 | $812K | Sell |
|
|||||
|
2021
Q2 | $896K | Buy |
|
|||||
|
2021
Q1 | $777K | Buy |
|
|||||
|
2020
Q4 | $601K | Sell |
|
|||||
|
2020
Q3 | $581K | Buy |
|